Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chanard

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 5, 2001
Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analysesO Toupance, M C Bouedjoro-Camus, J Carquin, et al.
Presse Medicale (Paris, France : 1983)|December 15, 1984
[Hemorrhagic fever with renal syndrome due to Hantaan virus or a serologically related virus]J P Melin, O Toupance, T Milcent, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|March 1, 1975
Kinetics of HBs antigen in manJ Drouet, A M Courouce-Pauty, A M Thevenoux, et al.
Nephrologie|November 9, 2000
[Severe Schonlein-Henoch nephritis in adults. A report of twenty cases]F Schillinger, P S Denis, J J Dion, et al.
BMJ (Clinical Research Ed.)|October 1, 1994
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failureT Hannedouche, P Landais, B Goldfarb, et al.
Calcified Tissue Research|August 1, 1976
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone diseaseA E Fournier, P J Bordier, J Gueris, et al.
Therapeutic Drug Monitoring|March 1, 1991
Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patientsJ B Lecaillon, J P Dubois, T Darragon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone diseaseA E Fournier, P J Bordier, J Gueris, et al.
Lancet (London, England)|October 11, 1980
Carnitine improves lipid anomalies in haemodialysis patientsB Lacour, S Di Giulio, J Chanard, et al.
Lancet (London, England)|January 14, 1984
Focus of muroid virus nephropathy in FranceJ Chanard, J P Melin, T Milcent, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Transplant International : Official Journal of the European Society for Organ Transplantation|January 5, 2001
Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analysesO Toupance, M C Bouedjoro-Camus, J Carquin, et al.
Presse Medicale (Paris, France : 1983)|December 15, 1984
[Hemorrhagic fever with renal syndrome due to Hantaan virus or a serologically related virus]J P Melin, O Toupance, T Milcent, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|March 1, 1975
Kinetics of HBs antigen in manJ Drouet, A M Courouce-Pauty, A M Thevenoux, et al.
Nephrologie|November 9, 2000
[Severe Schonlein-Henoch nephritis in adults. A report of twenty cases]F Schillinger, P S Denis, J J Dion, et al.
BMJ (Clinical Research Ed.)|October 1, 1994
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failureT Hannedouche, P Landais, B Goldfarb, et al.
Calcified Tissue Research|August 1, 1976
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone diseaseA E Fournier, P J Bordier, J Gueris, et al.
Therapeutic Drug Monitoring|March 1, 1991
Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patientsJ B Lecaillon, J P Dubois, T Darragon, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone diseaseA E Fournier, P J Bordier, J Gueris, et al.
Lancet (London, England)|October 11, 1980
Carnitine improves lipid anomalies in haemodialysis patientsB Lacour, S Di Giulio, J Chanard, et al.
Lancet (London, England)|January 14, 1984
Focus of muroid virus nephropathy in FranceJ Chanard, J P Melin, T Milcent, et al.
Pageof 14